Subscribe to our newsletter!
Follow the latest news from CATALIS and Clinical Trials Quebec
Clinical Trials Quebec has developed an Information Hub that includes several Direct Services to Users designed to inform, mobilize and engage them in clinical research in Quebec.
Unless the context indicates otherwise, grammatical variations of any defined term shall have the same meaning, and the singular shall include the plural and the masculine shall include the feminine (and vice versa).
Clinical Trials Quebec makes the following available to Users:
2.1.1 Support Service: This Service is intended to assist Users in their search and preliminary identification of clinical trials. The Support Service allows Users to be assisted by Clinical Trials Quebec to conduct targeted searches of clinical trials, and receive alerts (if clinical trials that meet their criteria become available or if the status of certain clinical trials changes). The terms and conditions applicable to this Service are available here.
2.1.2 Content. This Content is intended to provide Users with information and tools to namely raise awareness, inform and assist them in their awareness or understanding of certain subjects, or to facilitate exchanges between patients, caregivers and health care professionals.
2.1.3 Directory of patient organizations. This directory provides a list of patient organizations so that Users are able to contact them. The contact details and information found in the directory are updated by each organization.
Each User has the option of accessing and using the Information Hub or not. When sensitive or identifiable personal information is required to use a Service (i.e., Support Service, see here ), then express consent will be requested. In other cases, the Users’ implied consent may be sufficient.
The Information Hub is available free of charge. Usage fees charged by a User’s Internet or wireless service provider will apply independently and according to the use that will be made of their electronic devices.
Each User acknowledges and agrees:
3.1.1 That Clinical Trials Quebec holds all Intellectual Property rights as well as other rights, titles and interests in relation to: (i) the Information Hub (subject to content obtained from another source); and (ii) any other improvements to the Information Hub that may or may not benefit from separate protection;
3.1.4 That it is prohibited to remove, conceal or modify any right marks associated with the Information Hub or the Content (such as “©”);
3.1.5 The User shall notify Clinical Trials Quebec if it becomes aware of an infringement of Clinical Trials Quebec’s Intellectual Property rights and, where applicable, shall assist the User (at the latter’s expense) in any action to protect such Intellectual Property or to put an end to any infringement or other breach.
Users acknowledge and agree that any comments, ideas or other suggestions brought to the attention of Clinical Trials Quebec related to the Information Hub shall be the property of Clinical Trials Quebec. As a result, Users shall assign to Clinical Trials Quebec all of their rights, titles and interests, and waive their moral rights in such comments, ideas and other suggestions.
Users represent and warrant that:
4.1.1 They will only use the Information Hub for the Permitted Purposes;
4.1.2 They will not transfer or reproduce the Information Hub in whole or in part (with the exception of the Content for personal and non-commercial consultation purposes and if it originates from another source, in accordance with the terms and conditions applicable to that other source);
4.1.3 They will not access, authorize access to, or assist any person to access the Information Hub through any means (automated or otherwise) other than through a commercial browser (e.g., Chrome, Safari, Internet Explorer and Mozilla Firefox), and will not download any viruses, Trojan horses or other malicious code;
4.1.5 They will not: (i) transfer, create derivatives, sell, loan, lease, sub-license or otherwise transfer, in whole or in part, the rights and licences granted by Clinical Trials Quebec; (ii) grant rights to the Information Hub to third parties; (iii) copy, change, disassemble, use reverse engineering or decompilation processes, derive any source code, modify or otherwise extract, by any means whatsoever, any source code; (iv) distribute or make the Information Hub available, in whole or in part, to any person or on any network, platform or other means allowing their use by several devices at the same time; (v) use or operate the Information Hub in such a way as to harm the Services or Clinical Trials Quebec (including the initiative), or for any object other than the Permitted Purposes; (vi) use the Hub, in whole or in part, to harass, or otherwise harm any person; or (vii) attempt to do what is stipulated in (i) to (vi); and
4.1.6 Have not previously been prohibited, or otherwise restricted, from accessing and using the Information Hub, notably by Clinical Trials Quebec.
The rights and licences granted to Users shall be based on such representations and warranties, which are an essential condition thereof. If any of these were to no longer be accurate or applicable, then Users must stop accessing and using the Information Hub.
Even though the Information Hub was created using marketable technologies, any technology – as well as any other service or method of delivery – is never infallible or fully protected from unpredictable events, cyber attacks (and other illegal acts) or malfunction. In addition, Clinical Trials Quebec reiterates that the Information Hub: (i) Was not created to meet the specific needs of a given User; (ii) is provided for informational purposes and may not be used for any other purposes (including any hyperlinks available on it); (iii) may not be used for self-diagnosis purposes; and (iv) may not be seen as providing recommendations, interpretations and/or medical advice, or as a substitute for advice and/or assistance that can be obtained from professionals. Lastly, Clinical Trials Quebec reiterates that: (a) The Information Hub has been prepared with reasonable efforts to ensure the accuracy of the information contained therein, with the understanding that such an Information Hub, like any other information, may be or become inaccurate or outdated; (b) that any content from another source is reproduced “as is”; and (c) that it should not be seen as endorsing the Contents of the Information Hub.
Users understand that this Article 5 provides essential conditions for the rights and licences granted to them.
Clinical Trials Quebec may terminate access to the Information Hub at any time. Users may also stop accessing and using the Information Hub at any time, at their discretion and without any other formality. Accordingly, Users shall remain bound by any provision which, by its nature, shall continue to apply, including those provided for in Articles 3 (Property), 4 (Representations and Warranties), 5 (Responsibility) and 7 (Miscellaneous Provisions).
Instead of terminating access to the Information Hub, Clinical Trials Quebec may limit, restrict or interrupt their use or access, if they are defective (until the situation is corrected) or for any reason (for any reasonable period of time).
If a provision is in conflict with any law or is not subject to enforcement, then it shall be severable from the other provisions and deemed to be rewritten so as to be valid and enforceable while complying, inasmuch as possible, with its initial spirit and scope.
Clinical Trials Quebec is not liable for any harm resulting from a case of force majeure.
Any notices sent to Clinical Trials Quebec: (i) shall be in writing and sent by registered or certified mail, delivered by hand, or sent by email (with confirmation of transmission); and (ii) shall be received on the day of delivery or on the date indicated on the confirmation (of transmission or delivery) if received on a business day before 5:00 p.m. at the address provided here , failing which such notice shall be deemed to be received on the next business day.